Results 21 to 30 of about 6,247,718 (207)

D and N are different nominalizers

open access: yesGlossa, 2020
In this paper I argue for a split between NP and DP by showing that it accounts for crucial distinctions in the behavior of nominalizations. The NP-DP split is challenged not only by competing frameworks or theories that argue, for instance, that NPs and
Gianina Iordăchioaia
doaj   +2 more sources

Imaging of High‐Risk Neuroblastoma: Recommendations From SIOPEN Radiology and Nuclear Medicine Specialty Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Neuroblastoma is the most common extracranial solid tumor in early childhood. Its clinical behavior is highly variable, ranging from spontaneous regression to fatal outcome despite intensive treatment. The International Society of Pediatric Oncology Europe Neuroblastoma Group (SIOPEN) Radiology and Nuclear Medicine Specialty Committees ...
Annemieke Littooij   +11 more
wiley   +1 more source

$$d_{N \Omega }$$ d N Ω production in $$\Omega d$$ Ω d scattering process

open access: yesEuropean Physical Journal C: Particles and Fields
In the present work, we propose to investigate the production of $$d_{N \Omega }$$ d N Ω in the $$\Omega ^{-} d \rightarrow p d_{N \Omega }^-$$ Ω - d → p d N Ω - process by utilizing an effective Lagrangian approach, where $$d_{N \Omega }$$ d N Ω is ...
Quan-Yun Guo, Jing Liu, Dian-Yong Chen
doaj   +1 more source

Effects of Cancer Treatment on Somatosensory and Nociceptive Processing in Children and Adolescents: A Systematic Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Chemotherapy‐induced peripheral neuropathy remains a major complication in pediatric cancer, with disrupted somatosensory and nociceptive processing being a key aspect. This review synthesizes empirical studies on alterations in somatosensory and nociceptive processing in children and adolescents with cancer.
Julia Schweiger   +4 more
wiley   +1 more source

Correlation functions for $$n\,\bar{D}_{s1}(2460)$$ n D ¯ s 1 ( 2460 ) and $$n\,\bar{D}_{s1}(2536)$$ n D ¯ s 1 ( 2536 )

open access: yesEuropean Physical Journal C: Particles and Fields
We study the interaction of the $$n \bar{D}_{s1}(2460)$$ n D ¯ s 1 ( 2460 ) and $$n \bar{D}_{s1}(2536)$$ n D ¯ s 1 ( 2536 ) systems from the perspective that the $$D_{s1}(2460)$$ D s 1 ( 2460 ) and $$D_{s1}(2536)$$ D s 1 ( 2536 ) states are molecular ...
Breno Agatão   +5 more
doaj   +1 more source

Measurement of D0, D+, D*+ and D s + production in Pb-Pb collisions at s N N = 5.02 $$ \sqrt{{\mathrm{s}}_{\mathrm{NN}}}=5.02 $$ TeV

open access: yesJournal of High Energy Physics, 2018
We report measurements of the production of prompt D0, D+, D*+ and D s + mesons in Pb–Pb collisions at the centre-of-mass energy per nucleon-nucleon pair s N N = 5.02 $$ \sqrt{s_{\mathrm{NN}}}=5.02 $$ TeV, in the centrality classes 0–10%, 30–50% and 60 ...
The ALICE collaboration   +1003 more
doaj   +1 more source

Ob etimologii i semantike termina voršud/vožšud [On the Etymology and Semantics of the Term voršud/vožšud]; pp. 276-282 [PDF]

open access: yesLinguistica Uralica, 2014
The paper deals with the concept of воршуд/вожшуд in the Udmurt language, which used to serve as a theonym for one of the traditional deities. The word was preserved by Udmurt local groups living in a foreign-language environment.
Nadežda Šutova
doaj   +1 more source

Results of the Childhood Cancer and Leukaemia Group's United Kingdom Relapsed Wilms Tumour Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The United Kingdom relapsed Wilms tumour (UKW‐R) trial aimed to improve the historically low survival rates after relapse of Wilms tumour (WT) through a prospective national risk‐stratified protocol. The trial also evaluated efficacy and toxicity of high‐dose melphalan.
Sucheta J. Vaidya   +10 more
wiley   +1 more source

Little strings on D n orbifolds

open access: yesJournal of High Energy Physics, 2017
We explore two classes of 6d N = 1 0 $$ \mathcal{N}=\left(1,0\right) $$ little string theories obtained from type IIA/IIB NS5-branes probing D n singularities.
Joonho Kim, Kimyeong Lee
doaj   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy